Skip to main content
Erschienen in: Infection 1/2013

01.02.2013 | Clinical and Epidemiological Study

Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience

verfasst von: W. Kwon, J.-Y. Jang, E.-C. Kim, J. W. Park, I. W. Han, M. J. Kang, S.-W. Kim

Erschienen in: Infection | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Rapidly changing medical environments may have changed the microbiology of infected bile. The aim of our study was to identify the changing trends in microorganisms in biliary infections and examine their susceptibilities against currently recommended antibiotics.

Methods

Bile cultures taken between 1998 and 2010 at Seoul National University Hospital, a tertiary medical center, were retrospectively reviewed. From 1,403 patients, 3,425 microorganisms were isolated from 2,217 cultures. The cultures were then tested to determine the types of microorganisms and their antibiotic susceptibility.

Results

The five most frequently isolated microorganisms were Enterococcus (22.7 %) followed by Escherichia (13.2 %), Pseudomonas (10.9 %), Klebsiella (10.3 %), and Enterobacter (7.2 %). The trend in annual incidence indicated a growing emergence of Enterococcus (P < 0.001). Among Enterococcus, E. faecium acquired a dominant position (50.6 %), showing an increasing trend over the study period (P = 0.026). The incidence of vancomycin-resistant Enterococcus also showed an increasing trend (P < 0.001). Many of the commonly used antibiotics provided inadequate coverage for the more frequently encountered microorganisms. Multiple regression revealed that benign causes of obstruction and non-operative treatment harbor an increased risk for enterococcal growth (P = 0.001 and P = 0.027, respectively).

Conclusions

In contrast to earlier reports, we found that Enterococcus has emerged as the most frequently isolated microorganism from bile. The importance of enterococcal infection should be recognized, and currently recommended antibiotics need to be re-evaluated since in our bile cultures most provided inadequate coverage for the more frequently encountered microorganisms. The changes in the trends of microorganisms isolated from bile should be considered in cases where patients present with biliary obstruction.
Literatur
1.
Zurück zum Zitat Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin N Am. 1990;70:1297–312.PubMed Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin N Am. 1990;70:1297–312.PubMed
2.
Zurück zum Zitat Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc. 1994;40:716–21.PubMed Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc. 1994;40:716–21.PubMed
3.
4.
Zurück zum Zitat Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology. 1989;36:132–5.PubMed Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology. 1989;36:132–5.PubMed
5.
Zurück zum Zitat Dowidar N, Kolmos HJ, Lyon H, Matzen P. Clogging of biliary endoprostheses. A morphologic and bacteriologic study. Scand J Gastroenterol. 1991;26:1137–44.PubMedCrossRef Dowidar N, Kolmos HJ, Lyon H, Matzen P. Clogging of biliary endoprostheses. A morphologic and bacteriologic study. Scand J Gastroenterol. 1991;26:1137–44.PubMedCrossRef
6.
Zurück zum Zitat Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier; 2010. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier; 2010.
7.
Zurück zum Zitat Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 17th informational supplement. In: Institute CaLS, editor. CLSI document M100S17. Wayne: Clinical and Laboratory Standard Institute; 2007. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 17th informational supplement. In: Institute CaLS, editor. CLSI document M100S17. Wayne: Clinical and Laboratory Standard Institute; 2007.
8.
Zurück zum Zitat Fukunaga FH. Gallbladder bacteriology, histology, and gallstones. Study of unselected cholecystectomy specimens in Honolulu. Arch Surg. 1973;106:169–71.PubMedCrossRef Fukunaga FH. Gallbladder bacteriology, histology, and gallstones. Study of unselected cholecystectomy specimens in Honolulu. Arch Surg. 1973;106:169–71.PubMedCrossRef
10.
Zurück zum Zitat Suzuki Y, Kobayashi A, Ohto M, Tsuchiya Y, Saisho H, Kimura K, et al. Bacteriological study of transhepatically aspirated bile. Relation to cholangiographic findings in 295 patients. Dig Dis Sci. 1984;29:109–15.PubMedCrossRef Suzuki Y, Kobayashi A, Ohto M, Tsuchiya Y, Saisho H, Kimura K, et al. Bacteriological study of transhepatically aspirated bile. Relation to cholangiographic findings in 295 patients. Dig Dis Sci. 1984;29:109–15.PubMedCrossRef
11.
12.
Zurück zum Zitat Bae WK, Moon YS, Kim JH, Lee SH, Kim NH, Kim KA, et al. Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection. Korean J Gastroenterol. 2008;51:248–54.PubMed Bae WK, Moon YS, Kim JH, Lee SH, Kim NH, Kim KA, et al. Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection. Korean J Gastroenterol. 2008;51:248–54.PubMed
13.
Zurück zum Zitat Li QW, Ji F. A clinical study of bile cultures and antibiotic susceptibility test in the patients with operation on biliary tract. Zhonghua Wai Ke Za Zhi. 2009;47:527–9.PubMed Li QW, Ji F. A clinical study of bile cultures and antibiotic susceptibility test in the patients with operation on biliary tract. Zhonghua Wai Ke Za Zhi. 2009;47:527–9.PubMed
14.
Zurück zum Zitat Salvador VB, Lozada MC, Consunji RJ. Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center. Surg Infect (Larchmt). 2011;12:105–11. doi:10.1089/sur.2010.005.CrossRef Salvador VB, Lozada MC, Consunji RJ. Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center. Surg Infect (Larchmt). 2011;12:105–11. doi:10.​1089/​sur.​2010.​005.CrossRef
15.
Zurück zum Zitat Karpel E, Madej A, Buldak L, Dulawa-Buldak A, Nowakowska-Dulawa E, Labuzek K, et al. Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis. Scand J Gastroenterol. 2011;46:925–30. doi:10.3109/00365521.2011.560676.PubMedCrossRef Karpel E, Madej A, Buldak L, Dulawa-Buldak A, Nowakowska-Dulawa E, Labuzek K, et al. Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis. Scand J Gastroenterol. 2011;46:925–30. doi:10.​3109/​00365521.​2011.​560676.PubMedCrossRef
16.
Zurück zum Zitat Flores C, Maguilnik I, Hadlich E, Goldani LZ. Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. J Gastroenterol Hepatol. 2003;18:333–6.PubMedCrossRef Flores C, Maguilnik I, Hadlich E, Goldani LZ. Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. J Gastroenterol Hepatol. 2003;18:333–6.PubMedCrossRef
18.
Zurück zum Zitat Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc. 2002;56:885–9. doi:10.1067/mge.2002.129604.PubMedCrossRef Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc. 2002;56:885–9. doi:10.​1067/​mge.​2002.​129604.PubMedCrossRef
19.
Zurück zum Zitat Nomura T, Shirai Y, Hatakeyama K. Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction. Dig Dis Sci. 1999;44:542–6.PubMedCrossRef Nomura T, Shirai Y, Hatakeyama K. Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction. Dig Dis Sci. 1999;44:542–6.PubMedCrossRef
20.
Zurück zum Zitat Yu H, Guo Z, Xing W, Guo X, Liu F, Li B. Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Intervent Radiol. 2012;35:1136–44. doi:10.1007/s00270-011-0263-2. Yu H, Guo Z, Xing W, Guo X, Liu F, Li B. Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Intervent Radiol. 2012;35:1136–44. doi:10.​1007/​s00270-011-0263-2.
22.
Zurück zum Zitat Nomura T, Shirai Y, Hatakeyama K. Enterococcal bactibilia in patients with malignant biliary obstruction. Dig Dis Sci. 2000;45:2183–6.PubMedCrossRef Nomura T, Shirai Y, Hatakeyama K. Enterococcal bactibilia in patients with malignant biliary obstruction. Dig Dis Sci. 2000;45:2183–6.PubMedCrossRef
23.
Zurück zum Zitat Bryan CS, Reynolds KL, Brown JJ. Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet. 1985;160:557–61.PubMed Bryan CS, Reynolds KL, Brown JJ. Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet. 1985;160:557–61.PubMed
24.
Zurück zum Zitat McBride SJ, Upton A, Roberts SA. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review. Eur J Clin Microbiol Infect Dis. 2010;29:107–14. doi:10.1007/s10096-009-0830-5.PubMedCrossRef McBride SJ, Upton A, Roberts SA. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review. Eur J Clin Microbiol Infect Dis. 2010;29:107–14. doi:10.​1007/​s10096-009-0830-5.PubMedCrossRef
25.
Zurück zum Zitat Caballero-Granado FJ, Becerril B, Cuberos L, Bernabeu M, Cisneros JM, Pachon J. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis. 2001;32:587–94. doi:10.1086/318717.PubMedCrossRef Caballero-Granado FJ, Becerril B, Cuberos L, Bernabeu M, Cisneros JM, Pachon J. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis. 2001;32:587–94. doi:10.​1086/​318717.PubMedCrossRef
26.
Zurück zum Zitat Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91:S72–5.CrossRef Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91:S72–5.CrossRef
27.
Zurück zum Zitat Bush LM, Calmon J, Cherney CL, Wendeler M, Pitsakis P, Poupard J, et al. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med. 1989;110:515–20.PubMed Bush LM, Calmon J, Cherney CL, Wendeler M, Pitsakis P, Poupard J, et al. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med. 1989;110:515–20.PubMed
28.
Zurück zum Zitat Patterson JE, Zervos MJ. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis. 1990;12:644–52.PubMedCrossRef Patterson JE, Zervos MJ. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis. 1990;12:644–52.PubMedCrossRef
29.
30.
Zurück zum Zitat DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41:327–33. doi:10.1086/430909.PubMedCrossRef DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41:327–33. doi:10.​1086/​430909.PubMedCrossRef
31.
Zurück zum Zitat Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis. 2000;36:145–58.PubMedCrossRef Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis. 2000;36:145–58.PubMedCrossRef
32.
Zurück zum Zitat Thompson J, Bennion RS, Pitt HA. An analysis of infectious failures in acute cholangitis. HPB Surg. 1994;8:139–44. (discussion 45).PubMedCrossRef Thompson J, Bennion RS, Pitt HA. An analysis of infectious failures in acute cholangitis. HPB Surg. 1994;8:139–44. (discussion 45).PubMedCrossRef
33.
Zurück zum Zitat Yellin AE, Heseltine PN, Berne TV, Appleman MD, Gill MA, Riggio CE, et al. The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet. 1985;161:303–7.PubMed Yellin AE, Heseltine PN, Berne TV, Appleman MD, Gill MA, Riggio CE, et al. The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet. 1985;161:303–7.PubMed
34.
Zurück zum Zitat Walker AP, Nichols RL, Wilson RF, Bivens BA, Trunkey DD, Edmiston CE Jr, et al. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections. Ann Surg. 1993;217:115–21.PubMedCrossRef Walker AP, Nichols RL, Wilson RF, Bivens BA, Trunkey DD, Edmiston CE Jr, et al. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections. Ann Surg. 1993;217:115–21.PubMedCrossRef
35.
Zurück zum Zitat Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O’Marro S, et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg. 2000;232:254–62.PubMedCrossRef Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O’Marro S, et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg. 2000;232:254–62.PubMedCrossRef
36.
37.
Zurück zum Zitat Sirinek KR, Levine BA. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis. Surg Gynecol Obstet. 1991;172:30–5.PubMed Sirinek KR, Levine BA. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis. Surg Gynecol Obstet. 1991;172:30–5.PubMed
38.
Zurück zum Zitat Polk HC Jr, Fink MP, Laverdiere M, Wilson SE, Garber GE, Barie PS, et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The piperacillin/tazobactam intra-abdominal infection study group. Am Surg. 1993;59:598–605.PubMed Polk HC Jr, Fink MP, Laverdiere M, Wilson SE, Garber GE, Barie PS, et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The piperacillin/tazobactam intra-abdominal infection study group. Am Surg. 1993;59:598–605.PubMed
39.
Zurück zum Zitat Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997–1005. doi:10.1086/378702.PubMedCrossRef Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997–1005. doi:10.​1086/​378702.PubMedCrossRef
41.
Zurück zum Zitat Marne C, Pallares R, Martin R, Sitges-Serra A. Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile. Eur J Clin Microbiol. 1986;5:35–9.PubMedCrossRef Marne C, Pallares R, Martin R, Sitges-Serra A. Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile. Eur J Clin Microbiol. 1986;5:35–9.PubMedCrossRef
42.
Zurück zum Zitat van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279–86.PubMedCrossRef van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279–86.PubMedCrossRef
43.
Zurück zum Zitat Gilbert DN, Moellering RC, Eliopoulis GM, Saag MS, Chambers HF. The Sanford guide to antimicrobial therapy 2011. 39th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2011. Gilbert DN, Moellering RC, Eliopoulis GM, Saag MS, Chambers HF. The Sanford guide to antimicrobial therapy 2011. 39th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2011.
44.
Zurück zum Zitat Negm AA, Schott A, Vonberg R-P, Weismueller TJ, Schneider AS, Kubicka S, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc. 2010;72:284–91. doi:10.1016/j.gie.2010.02.043.PubMedCrossRef Negm AA, Schott A, Vonberg R-P, Weismueller TJ, Schneider AS, Kubicka S, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc. 2010;72:284–91. doi:10.​1016/​j.​gie.​2010.​02.​043.PubMedCrossRef
Metadaten
Titel
Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience
verfasst von
W. Kwon
J.-Y. Jang
E.-C. Kim
J. W. Park
I. W. Han
M. J. Kang
S.-W. Kim
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 1/2013
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0358-y

Weitere Artikel der Ausgabe 1/2013

Infection 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.